JP Morgan Chase’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.3K Sell
1,468
-148
-9% -$3.46K ﹤0.01% 6416
2025
Q4
$49.7K Buy
1,616
+1,126
+230% +$25.2K ﹤0.01% 6228
2025
Q3
$7.96K Sell
490
-2,879
-85% -$32.9K ﹤0.01% 6698
2025
Q2
$29.8K Sell
3,369
-6,364
-65% -$58K ﹤0.01% 6078
2025
Q1
$105K Sell
9,733
-11,930
-55% -$146K ﹤0.01% 5547
2024
Q4
$277K Buy
21,663
+16,826
+348% +$334K ﹤0.01% 5334
2024
Q3
$134K Sell
4,837
-20
-0.4% -$588 ﹤0.01% 5584
2024
Q2
$141K Sell
4,857
-27,874
-85% -$1.33M ﹤0.01% 5349
2024
Q1
$1.46M Buy
32,731
+24,601
+303% +$1.05M ﹤0.01% 4077
2023
Q4
$315K Sell
8,130
-4,593
-36% -$165K ﹤0.01% 5077
2023
Q3
$374K Buy
12,723
+954
+8% +$45.3K ﹤0.01% 4651
2023
Q2
$748K Sell
11,769
-19,481
-62% -$1.08M ﹤0.01% 4253
2023
Q1
$1.48M Buy
31,250
+2,643
+9% +$141K ﹤0.01% 3762
2022
Q4
$1.99M Buy
28,607
+2,607
+10% +$259K ﹤0.01% 3561
2022
Q3
$3.81M Sell
26,000
-359
-1% -$48.6K ﹤0.01% 2971
2022
Q2
$3.44M Buy
26,359
+439
+2% +$44.9K ﹤0.01% 3103
2022
Q1
$2.62M Buy
25,920
+2,702
+12% +$327K ﹤0.01% 3546
2021
Q4
$3.59M Buy
23,218
+6,114
+36% +$1.36M ﹤0.01% 3334
2021
Q3
$5.06M Buy
+17,104
New +$5.12M ﹤0.01% 3013

Other funds holding LYEL